Baird Financial Group
EXAS

Baird Financial Group’s Exact Sciences EXAS Stock Holding History

Baird Financial Group’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-309,269
Closed -$31.4M – 1864
2025
Q4 		$31.4M Sell
309,269
-27,980
-8% -$2.25M 0.05% 257
2025
Q3 		$18.5M Buy
337,249
+56,901
+20% +$2.84M 0.03% 392
2025
Q2 		$14.9M Sell
280,348
-30,218
-10% -$1.54M 0.03% 428
2025
Q1 		$13.4M Sell
310,566
-25,414
-8% -$1.29M 0.03% 443
2024
Q4 		$18.9M Buy
335,980
+9,045
+3% +$563K 0.04% 364
2024
Q3 		$22.3M Buy
326,935
+43,561
+15% +$2.46M 0.04% 316
2024
Q2 		$12M Sell
283,374
-13,503
-5% -$743K 0.02% 434
2024
Q1 		$20.5M Sell
296,877
-36,023
-11% -$2.28M 0.04% 319
2023
Q4 		$24.6M Buy
332,900
+95,062
+40% +$6.23M 0.06% 281
2023
Q3 		$16.2M Buy
237,838
+743
+0.3% +$63K 0.04% 329
2023
Q2 		$22.3M Buy
237,095
+16,191
+7% +$1.26M 0.06% 278
2023
Q1 		$15M Buy
220,904
+24,804
+13% +$1.59M 0.04% 352
2022
Q4 		$9.71M Sell
196,100
-13,275
-6% -$542K 0.03% 444
2022
Q3 		$6.8M Buy
209,375
+26,542
+15% +$1.09M 0.02% 496
2022
Q2 		$7.2M Sell
182,833
-4,315
-2% -$231K 0.02% 506
2022
Q1 		$13.1M Buy
187,148
+2,934
+2% +$214K 0.03% 388
2021
Q4 		$14.3M Sell
184,214
-10,439
-5% -$921K 0.03% 377
2021
Q3 		$18.6M Buy
194,653
+4,000
+2% +$422K 0.05% 319
2021
Q2 		$23.7M Sell
190,653
-161
-0.1% -$19.2K 0.06% 274
2021
Q1 		$25.1M Sell
190,814
-15,867
-8% -$2.17M 0.07% 254
2020
Q4 		$27.4M Sell
206,681
-10,678
-5% -$1.29M 0.08% 236
2020
Q3 		$22.2M Sell
217,359
-8,058
-4% -$696K 0.08% 250
2020
Q2 		$19.6M Buy
225,417
+10,677
+5% +$853K 0.07% 247
2020
Q1 		$12.5M Buy
214,740
+20,038
+10% +$1.63M 0.06% 287
2019
Q4 		$18M Sell
194,702
-5,615
-3% -$494K 0.06% 276
2019
Q3 		$18.1M Sell
200,317
-3,183
-2% -$363K 0.07% 257
2019
Q2 		$24M Sell
203,500
-546
-0.3% -$55K 0.09% 228
2019
Q1 		$17.7M Buy
204,046
+39,770
+24% +$3.39M 0.1% 234
2018
Q4 		$10.4M Sell
164,276
-51,014
-24% -$3.5M 0.07% 283
2018
Q3 		$17.1M Buy
215,290
+52
+0% +$3.39K 0.11% 225
2018
Q2 		$12.9M Buy
215,238
+6,714
+3% +$361K 0.09% 257
2018
Q1 		$8.41M Sell
208,524
-5,215
-2% -$254K 0.06% 324
2017
Q4 		$11.2M Sell
213,739
-25,163
-11% -$1.34M 0.08% 259
2017
Q3 		$11.3M Sell
238,902
-912
-0.4% -$36.7K 0.08% 251
2017
Q2 		$8.48M Sell
239,814
-103,765
-30% -$3.2M 0.07% 287
2017
Q1 		$8.12M Sell
343,579
-24,017
-7% -$476K 0.07% 297
2016
Q4 		$4.91M Sell
367,596
-973
-0.3% -$15.7K 0.04% 374
2016
Q3 		$6.84M Buy
368,569
+9,121
+3% +$161K 0.06% 312
2016
Q2 		$4.42M Sell
359,448
-24,398
-6% -$184K 0.04% 383
2016
Q1 		$2.59M Buy
383,846
+47,121
+14% +$301K 0.02% 480
2015
Q4 		$3.11M Sell
336,725
-229,516
-41% -$2.13M 0.03% 437
2015
Q3 		$10.2M Buy
566,241
+18,634
+3% +$428K 0.11% 196
2015
Q2 		$16.3M Buy
+547,607
New +$13.8M 0.16% 164

Other funds holding EXAS

VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.16B AUM 28.78% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.68B AUM 31.18% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return
BC
Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

Baird Financial Group's EXAS Position: Q1 2026 in Review

Baird Financial Group sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 309,269 shares — an estimated $31.4M sold.

Baird Financial Group first reported a position in EXAS in Q2 2015 and held it in 43 quarters. The position peaked at $31.4M in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Baird Financial Group reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Baird Financial Group sold 309,269 Exact Sciences shares in Q1 2026, an estimated $31.4M.
  • Baird Financial Group first reported a position in Exact Sciences in Q2 2015 and held it in 43 quarters.
  • Baird Financial Group's Exact Sciences position peaked at $31.4M in Q4 2025.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Baird Financial Group's 13F filing for Q1 2026, filed 14 May 2026.